420 Stock Talk Forum Officially Opens, Requests Made By ATTBF Investors

Ladies and gentlemen, with great pleasure, I am happy to announce that the new 420 Stock Talk Forum is now officially open and available for new members to sign up.

This was originally inspired by ATTBF investors looking for an alternative to discussing the company on I-Hub.  However, if there’s another marijuana stock that new members would like me to create an additional board for, please let me know.

I’ve been receiving comments from I-Hub users for a few months now that are particularly frustrated with the quality of the discussion on the boards.  Some users feel that the rules and procedures aren’t enforced properly.  Others have criticized I-Hub for not being proactive in filtering out “trolls” and antagonists that appear to delight in causing trouble and creating dissonance.

So, I decided to spend a little more time than average reviewing the posts on the Abattis I-Hub section this past week.  I really wanted a better understanding of why many contributors felt the need to express their grievances.

Just a quick disclaimer about my intentions here

I want to start by saying that there are both pros and cons to using I-Hub.  I’m specifically focusing on the complaints I received and matching them with my own experience.

I do want to make it clear, however, that by creating a new forum, I’m not trying to create some massive feud in which you’re either “with us or against us.”  In my opinion, I-Hub is great for some things, terrible for others.  There’s no problem with using multiple discussion boards, and I suspect most active contributors in I-Hub already do this.

Moving on to my little Investors Hub research project…

It’s my understanding that if you’re willing to pay a monthly fee, the I-Hub experience can be a little less overwhelming.  But, as the average “free” contributor, you’re constantly clicking “Next,” waiting for awkwardly formatted browser windows to slowly load, while being barraged with advertisement after advertisement….

Many of the ads don’t even appear to be properly integrated or compatible with the forum scripts.  Every so often (about 1 in 8-10 page views or so), an I-Hub page suffers a total meltdown, in which the advertisement prevents a user from being able to properly click on links OR you are forced to scroll down for about 5-10 seconds to find a comment table that has been broken and shoved to the bottom of an obnoxiously enlarged page.

You’ll also find several regular contributors with questionable motives on I-Hub, especially the ATTBF section.  I can understand why someone would be frustrated with Abattis, and I’ve openly discussed this in previous articles.  But as to why a forum member that makes a daily effort to ridicule and tease investors would not eventually be tossed out the doors by the administration is beyond me.

Yes, the Investors Hub brings a lot of different people to the table, but at the same time, you have to contend with advertisement glitches and poorly framed pages (which wastes the time of the reader), a daily circus by childish antagonists, and apparently good posts also have a way of mysteriously disappearing.

So, I get it.  It does make perfect sense to me why some people are sick and tired of I-Hub.

This is why, upon request from certain ATTBF enthusiasts, I’ve just created a new forum that anyone is welcome to join for free and contribute their opinions.  Based on some of the complaints I’ve received, I want to reassure some people of what we will NOT do:

We will NOT allow a blatant troll to hold on to a Moderator position and wreak havoc

We will NOT randomly discard your post and leave you wondering how you could have possibly violated the rules or TOS

We will NOT allow nuisances and troublemakers to steal the show and plug up the community with garbage posts

We will NOT push 50 ads per page on you and make the process of reading discussions a hellish nightmare

So if you’re interested in helping to create a community that engages in healthy, beneficial discussion regarding ATTBF and other stocks, we’d invite you to check out our new forums at:


We’re now officially open!

Read More

Abattis – ATTBF Investors Sing The Blues As CEO Mike Withrow Unexpectedly Exits The Throne Room

I’m not a fan of hosting pity parties or erupting with obnoxious levels of optimism to help sugercoat a painful experience.

The Abattis CEO and former mastermind, Mike Withrow, that many investors came to respect over these past couple years has been replaced with William Fleming.  ATTBF fell below 10 cents per share and is sitting deep in the red.

Financial data was released on 1/28, and aside from a little revenue from Phytalab, the big buck opportunities are yet to be witnessed.

There it is.  That’s the reality.  For the longs, this hurts.

Following these discouraging announcements, many long term ATTBF investors have officially thrown in the towel, washed their portfolio clean of the remaining shares, and made no hesitation in voicing their anger and disappointment.

Do I blame them?  No.  I’m also disappointed.

And for the ATTBF investors acting as if they’re overjoyed that the stock they bought at 20 cents — or 50 cents — or even 2 dollars — is now sitting between 7 and 10 cents because it provides a new, incredible buying opportunity — let’s get real.  You may be stocking up right now, but you’re also feeling the pain with everyone else.

Will I follow the sellers?  NO.  Not based on these events alone.

This story has yet to entirely play out, and it’s very easy to lose focus of the long term possibilities, while solely concentrating on the potential catastrophes, when you’re smacked upside the head with multiple disappointments all at once.

Yes, I have mixed feelings about what transpired in January 2015.  Although it’s easy to touch on the negatives, I think we should also carefully take time to reflect on some positives.

I want to congratulate a rather popular Abattis advocate on both the Investors Hub community and Twitter who goes by “Shark Attack.”  This individual just recently presented an excellent 12 point summary explaining why he remains an ATTBF long on I-Hub, and it’s worth the read for anyone sitting on either side of the fence.

You can read the official posting here, but I’ve also provided a copy below, since I’ve had a couple of my readers imply that posts often mysteriously disappear on I-Hub.

Originally posted on Thursday, 01/29/15 08:46:54 AM

Shark Attack Abattis

Read More

You Can’t Push Abattis CEO Mike Withrow Around – Lessons From Vertical Designs and Affinor Battle

Mike Withrow

If you follow Abattis Bioceuticals closely enough, you may have felt as if you were reading a suspense novel during the month of December and especially after Christmas of 2014.

Shortly after Abattis was able to successfully add to its legal victories over Herbal Analytics, Affirnor Growers, LLC, Nicholas Brusatore, et al (please see “Abattis Obtains Preliminary Injunction Against Defendants In King County, Washington State Court..”), Vertical Designs Ltd. (VDL) issued a notice that the license with Abattis had been officially terminated due to a breach of the agreement.

Abattis CEO Mike Withrow didn’t waste any time.  The very next day, he issued a statement rejecting the termination notice, claiming that Abattis maintained possession of the license, and suggesting that further legal proceedings against VDL would likely ensue in the near future.

Most fascinating of all, Mike showed no intentions of holding back his true feelings.  He openly criticized the VDL statement as an effort to “retaliate against Abattis and its shareholders” and further described those responsible for the announcement as “schemers.

If you visit message boards and other internet media, you’ll find some Abattis (ATTBF) and Affinor (RSSFF) holders bickering back and forth over these issues, almost like a grudge match.  Amid the banter, however, you’ll also find some very interesting discussions about Nick Brusatore of Affinor.  Some specifically berate Brusatore for playing games and issuing “fluff PR’s” as backlash for Abattis’ victories.

I remain confident in Abattis Bioceuticals (ATTBF) and here’s why……

I’m not about to dive into any legal arguments or make conclusions about the future outcome of any legal battles.  I’ll leave that to Abattis management and the courts, as it appears ATTBF already has the upper hand.

But I will say this.  I don’t believe for a split second that Mike Withrow would have been so frank and presented such bold statements on December 31 (2014) about the suspected purpose behind VDL’s statement —unless— he was especially confident that it was true.

If there was merit to VDL’s claim, December 31st and the following days would most likely have been met with complete silence from Abattis.  Mike isn’t the type to call specific attention to a situation while knowing it’s highly likely to blow up in his face a few months down the road.

This isn’t a football game.  This is an investment.

I’m aware that any CEO can puff out his chest and gather praise and admiration from his stock holders for “looking tough.”

Bear in mind that there’s a right way and a wrong way to stand up for your company and demonstrate leadership.  For example, if you want to see a perfect, recent example of a CEO leading the way to absolute disaster in the marijuana industry, I recommend you research Bill Chaaban of FITX and his arrogant communication style.

But rest assured that the goal here with Abattis and Mike’s statements isn’t simply to motivate investors to swing their pom-poms and cheer faster.  Instead it’s a declaration that Mike understands shareholders’ frustration and he’s not going to tolerate competition and “schemers” that overstep their bounds.  Mike clarified his stance while maintaining his professionalism.

I, for one, am very pleased with the way he handled this situation.  It’s made me feel a lot more confident with Mike at the wheel, steering the Abattis ship.

Read More

Abattis (ATTBF) Already Performing Marijuana Growth Testing with LED Light?

The Abattis (ATTBF) share price has been taking a beating for a long time.  To the untrained eye, the company appears to be standing still and not showing any progress.

The dirty tango between Affinor and Abattis, including some downright suspicious P.R. moves by Affinor, isn’t helping matters either.  Would it be any surprise to learn that many investors have been selling out of sheer frustration the past few months?

Since ATTBF investors are already on edge, I’m not going to build up suspense and start some obnoxious 30 second drumroll.  Instead, I’m going to cut to the chase and just explain what I think is… or will officially be… good news.

I believe Abattis is currently undergoing testing with LED technology –but– they will be unable to announce the success and future implications of the trials for a while, possibly a few more months.

I’ve gathered a lot of clues from different sources, and some new visual evidence helped confirm by original suspicions.  Let’s first revisit a twitter picture post made on Nov 19, 2014 by Mr. Brayden Sutton, whom apparently had the pleasure of touring the BioCube and LED light technology.

Biocube Tour - Nov 19
Take a minute to note the little details in the room.  You’re about to see something very similar again soon.

Although we could determine that Abattis had created an environment for their technology, no word or follow-up about the testing ever surfaced.  Some investors even claimed that upon contacting the company in December, Abattis denied that the testing had even started.  The lack of progress disheartened some outspoken investors, but then…

Not too much later, right before Christmas of 2014, a site known as Led Horticulture posted several pictures about an anonymous LED light test being performed with medical marijuana via GrowthStarLED.


Go ahead and view some of the pictures for the full effect.  I thought this picture was the most interesting:

GrowthStarLED Test
See the resemblances to the twitter picture posted earlier?

Yes it’s true that the two pictures would have been taken from completely different angles, and under different lighting effects.  It’s not bulletproof evidence by itself, and I won’t argue that.

One specific and very intriguing section on the LED Horticulture blog post states:

This Vancouver producer asked to stay anonymous because of strict new Medical marijuana advertising laws in Canada that require them not to make marijuana products so appealing.

For those that don’t know, Abattis is headquartered in Vancouver, BC.

They also bring up another noteworthy point about advertising.  Don’t expect Abattis to confirm or deny any of this.  Not yet anyway.

Massive production of marijuana is still a very sensitive topic in both the U.S. and Canada as well.  I’m also sure Health Canada is aware and uncomfortable with the fact that many hopeful MMPR licensed growers were having a field day, constantly touting their plans and projections on Facebook, Twitter and “you name it,” while watching their stock prices soar.

The last thing Abattis would want to risk is their professional reputation with the Canadian government.  I don’t expect any confirmation from Mike Withrow about Abattis testing until they are good and ready.  And so it should be.

If you dumped your ATTBF stock during the final months of 2014 because you grew impatient, waiting for some juicy P.R., I think you’re going to really regret it.  ATTBF needs to be treated as a long term investment.

Complicated strategies surround this company and any serious investor hoping to eventually be rewarded will need to show a little endurance.

Read More

MCIG stock delisted to OTC Pink and CEO Paul Rosenburg is taking some heat

MCIG stock 9/4/14

Previously, I’ve been a big fan of one of the most popular marijuana stocks, mCig Inc. (OTC: MCIG) and it’s CEO, Paul Rosenberg.

But NOT today….. In fact, not even this week.

MCIG was recently delisted from the OTCQB to OTC Pink, which is considered the most risky tier of OTC stocks.  This transition created an immediate blow to the very image of the company.

And this leaves both long term critics of MCIG stock and loyal shareholders speculating over everything from the possibility of company going out of business to being a scam.

Here’s one example that caught my eye earlier this morning on the ever-so endearing Investors Hub boards.  This is especially concerning, because it goes back to issues I discussed last week about investors growing tired of waiting for the Vitacig spin-off to materialize:

MCIG Ihub shortorlong

MCIG Management is being called “incompetent” and “ignorant” quite openly, and it’s hard to blame investors when they watch such a rapid decline of a popular stock that’s previously enjoyed some stability (relatively speaking) in this marijuana stock sector.

Here’s yet another iHub clip that covers one of the primary reasons I shook my head with frustration when I learned about the delisting:

MCIG Ihub hobowilly

I do believe most investors or onlookers are going to simply see the stock listed as PINK and quickly come to the most negative conclusions without even conducting any further research.  Simply put, it’s seemed to become a deadly killer of any positive MCIG investor sentiment out there.

It’s difficult to make any predictions where this stock goes in the short term.  If you’re still invested in MCIG stock and wondering whether to bail or pick up more seemingly “cheap” shares, you’ll need to dig into the fundamentals of the company and pay attention to management’s attempts to rectify this blow to investor confidence.

It’s worth noting that MCIG did pay the $10,000 to be relisted to the OTCQB, but there’s still plenty of blood in the streets.

Disclaimer:  I am long MCIG stock, but only a small amount.  The actual value of my shares has decreased below $1,000 as of this posting.

Read More

MCIG Stock Painted Red. Let’s Bring Out That VitaCig Spin-Off Already!

Mcig 2.0 and VitaCig

Oh that MCIG! They can put on quite a show and draw a crowd.

Securing brand ambassadors like rapper Rick Ross, entertainer and “Jackass” founder, Bam Margera, and Jonathan Cheban of “Keeping Up With The Kardashians” has brought a lot of awareness to their up and coming brand.

Rising in popularity, we not only see the mCig, but also a smoke and nicotine-free product with nothing but water and vitamins: VitaCig.

They even have plans to enter the new alcohol vaporization market with LiqCig, which will be 100% owned by mCig, Inc.  Put into the absolute simplest of terms, there’s a lot you can like about owning MCIG stock long term.

But I sure do NOT like the recent downturn of the stock price…..

MCIG Stock Double Bottom August 27th 2014

Patterns count, whether you love or hate all the technical analysis mumbo jumbo, and this recent pattern is disconcerting.

MCIG stock has wavered in the mid 40 cents range for many months, and ascended as high as 53 cents during that same time.

A technical analyst would probably draw attention to the double bottom formation, but here’s the problem with viewing that signal as a golden opportunity to buy…..

MCIG just recently fell apart to the mid 30‘s, and the support level at 40 cents that previously held strong like an ancient Spartan warrior defending his homeland, collapsed like a tower of cards.

So is this just temporary frustration being expressed by current MCIG investors?  Or is this a good time to buy on the cheap side?

I think a lot of current MCIG stock enthusiasts have been holding and awaiting news that the company is going to move forward with the VitaCig spin-off, which will provide a 1:1 VitaCig stock dividend to MCIG owners.

This process continues to be delayed and holders seem to be growing tired.

The volume being traded has been strikingly low.  All it takes is for a small group of investors to say “I’ve had it!  I’m sick of waiting for this VitaCig spin-off and I’m dumping this!” to bring about such a rapid decline in the share price with these terrible volume numbers.

Considering its low revenue numbers and the sheer amount of e-cig competition emerging, a negative reaction is understandable.  MCIG was previously trading at a valuation well over $100 million.

MCIG is diversified, able to appeal to the younger generations, and seems intent on gobbling up market share through very flashy exposure.  But the valuation may be getting ahead of itself.  There’s a lot of revenue to be gained before I can feel completely at ease with a triple digit million valuation.

That’s why it’s so hard to determine if this 30 cent dance is a hiccup from impatience and low volume, or if it’s a necessary correction for a valuation that crept up way too high in MCIG’s infancy.

Disclaimer:  I am currently long MCIG.  And NO, I have not sold following the breakdown of the 40 cent levels, but I am accepting extra risk as a long-term holder.

Read More

FITX stock dripping through the grates of CEO Bill Chaaban’s grill?

Selling FITX Stock

Prepare for a discussion regarding a company and stock where emotions seem to always run wild……….

I know some die-hard FITX stock holders would rather spit in my face than read anything discussed in a negative light about Cen Biotech (FITX) or it’s CEO, Bill Chaaban.  Note that I’m not trying to ruin your “hur-rah!”  I’m just sorting through the developments and detailing what stands out and concerns me most.

I also have bad news for the FITX contenders.  This isn’t a bash fest I’m about to unleash.  At least, that’s not my intention.

One commonly voiced concern is that entrepreneurs should be rewarded for success and hard work, and while it’s not entirely fair to say “Bill Chaaban has accomplished nothing yet,” the long road toward FITX developing into a sustainable, productive business has only begun.

And Bill has been gradually unloading his FITX shares for a while now.

You can accept a popular rebuttal to this – that it’s smart for a CEO or any director to take some profits as the stock price rises, if for no other reason than to start gaining back some of his personal initial investment.  Or also to liquidate some of the rewards for working hard and running the company.

So why exactly do many current FITX stock investors and also critics continue to voice their concern about Bill Chaaban selling his shares?  Mainly because he specifically stated in the earlier stages of this year that he would not be selling.

Also, there’s some frustration that Cen Biotech still has not received the MMPR license from Health Canada and cannot begin medical marijuana production in Lakeshore, Ontario.  Receiving the license has taken considerably longer than Bill and many investors anticipated.

But let’s go back to the insider selling topic.  One of FITX’s most outspoken critics, Matt Finston, recently published a listing on iHub, detailing the dates in which Bill sold his shares.  Pardon the far-from-perfect formatting, it still should be rather easy to interpret:

FITX shares sold by BillMatt further reports that the total proceeds are $3,636,238 and a total number of 47,360,399 shares have been sold at an average price of $0.0768.

Here’s my latest concern and thought about these FITX stock dumps by the CEO.  The current “high” valuation of the company is often critiqued, and I agree that the hype factor surrounding FITX is primarily responsible for this.

Maybe Bill strongly agrees with this as well.  He’s been disposing since February 2014 from 0.0972, and now we see the latest series of selling in the 5 cent range.  Bill has cooked up a lot of enthusiasm for long term investors over the past several months, but now his own holdings appear to be slowly dripping away.

I won’t draw out a long series of possible explanations for this, as those lists could run on forever if you have a powerful enough imagination.  I just leave you with one gnawing question that I’ve been pondering for a while now:

If Bill Chaaban doesn’t prefer keeping FITX at these share prices, WHY should we?

Disclaimer:  I have no positions in FITX stock, and quite frankly, would never even think about shorting it.  Be very careful no matter what position you are inclined to take here.

Read More

Buying ATTBF stock (Abattis Bioceuticals) before the reversal? The charts are speaking.

Technical analysis is one of those touchy subjects that can get you in trouble if you don’t plan your buying or trading carefully.  That’s especially true when dealing with marijuana penny stocks.

But every candlestick tells a story, even with highly volatile stocks.  Let us not forget that.  And there may be a couple good omens for current ATTBF stock holders and for investors sitting on the sidelines wondering when they should take a long position in Abattis Bioceuticals.

Let’s go to the charts for some insight, shall we?

Abattis stock chart, August 15

What are the charts saying?

First of all, we see a very important bullish candlestick on 8/13/14 – the Hammer.  For those unfamiliar, this signals that the strength of the bulls are gaining, and often (though certainly not always) precedes a reversal of the trend.

This isn’t the “perfect” Hammer, in which ideally the top shadow wouldn’t have existed, but it’s a Hammer followed up a slight movement upward in any case.

Secondly, we have the clear-as-day (in this case) Double Bottom.  The stock dropped to a strong support level around 0.38-0.40, ascended to the mid 0.70’s, and then re-tested the same 40 cents support all over again.

Where do we go from here?

On this chart, we can only see a couple days of positive follow up.  What would be excellent to see, if you’re currently long ATTBF or planing on buying in soon, is a return to 50 cents in the near future.  That would give credence to some of these nudges suggesting that a “reversal is on the way.”

In the long term, we need to see a breakthrough past the 70 cents levels.  Excitement got the best of some buyers at the height of the last run-up, in which ATTBF fell pretty sharply by over 20% in just a few days.  This time around, if we see a continued drive to the $1.00 mark, it would speak volumes for long term investors sentiment and interest.

And if you’re looking to invest in the marijuana stocks which have the highest likelihood of sticking out the evolution of the sector, long term is what it’s all about.

Disclaimer:  ATTBF stock is by far my largest position in my marijuana / penny portfolio.  I love the management team, I love the diversification strategies, and (going off a popular Mark Twain quote), I like that Abattis is looking to sell picks and shovels right as a new gold rush is emerging.

Read More

Jason Barkeloo selling off Tauriga Sciences (TAUG) stake?

Selling FITX Stock

Some TAUG (Tauriga Sciences, Inc) investors aren’t particularly pleased with what appears to be some impatience on Jason Barkeloo and Bacterial Robots’ part.  Per the Form 4 filed on 8/12/14, Mr. Barkeloo disposed of TAUG securities in the following amounts:

8/8/14 — 1781000

8/11/14 — 1719000


The frustration is understandable in context.  TAUG flew ahead from 0.02 to almost 0.06 a share from late June to mid July.  This was followed by a test of endurance from loyal holders, as TAUG stock has gradually declined back below 0.03.  You can’t blame Barkeloo for wiping out the entire 3 week 200% gain, but at the same time, it certainly doesn’t help steer the price in the other direction.

No point in dragging out too much speculation at this point.  The good news is that TAUG CEO Stella Sung is often praised for her transparency and willingness to communicate directly with shareholders.  If you’re a concerned shareholder, it sounds like she’ll be happy to answer your questions.  Don’t be afraid to give them a call.

Read More

mCig (MCIG) drives another endorsement, claims 10-K will show 1,100% increase in revenue

Mcig 2.0 and VitaCig

10-k will be released on Friday. The Company expects to report approximately $543,000 in company-wide pro-forma* revenue. This figure includes pro-forma revenue for mCig, Inc., VitaCig, Inc., and Vapolution, Inc. for the year ended April 30, 2014**. This compares with approximately $50,000 in the prior-year ended April 30, 2013 and represents an approximate 1,100% increase. The Company expects to report profitable Adjusted Earnings* for the year ended April 30, 2014. The Company expects to report approximately $353,000 in company-wide pro-forma* gross profit for the year ended April 30, 2014.

This reflects a gross profit margin of approximately 65%. These financial results reflect only 15 days of sales for VitaCig (launched on April 15, 2014) and only 103 days for mCig inclusive of days where the company ran out of inventory.

Read More